Shailaja Chidella, MD
Nephrology · Lawrenceville, GANPI 1376786871
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $455, 2.1 times the $213 reported in 2019. That places this record below the midpoint for nephrology clinicians in GA, where the typical reported total is $1,554.
Across 86 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$314
- AstraZeneca$206
- Otsuka America Pharmaceutical, Inc.$197
- Bayer$143
- Vifor Pharma, Inc.$126
- Novartis$104
- plus $604 from 12 others
What the payments were for
- Food & beverage$1,63596%
- Education$614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 16 | $314 |
| AstraZeneca(2 entities) | 11 | $206 |
| Otsuka America Pharmaceutical, Inc. | 7 | $197 |
| Bayer | 7 | $143 |
| Vifor Pharma, Inc. | 5 | $126 |
| Novartis | 7 | $104 |
| OPKO Pharmaceuticals, LLC | 5 | $98 |
| Aurinia Pharma U.S., Inc. | 6 | $97 |
| Sanofi | 3 | $87 |
| GSK | 5 | $71 |
| Fresenius USA Marketing, Inc. | 3 | $62 |
| Calliditas Therapeutics US Inc. | 3 | $53 |
| Travere Therapeutics, Inc. | 2 | $31 |
| Apellis Pharmaceuticals, Inc. | 2 | $30 |
| Leadiant Biosciences, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,696 in reported general payments places this provider in the 50th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Torsemide | 36 | $716 |
| Doxazosin Mesylate | 12 | $301 |
| Calcitriol | 41 | $238 |
| Allopurinol | 33 | $212 |
| Lisinopril | 16 | $125 |
| Amlodipine Besylate | 21 | $116 |
| Tamsulosin Hcl | 13 | $114 |
| Carvedilol | 23 | $87 |
| Furosemide | 20 | $84 |
| Gabapentin | 11 | $74 |
| Losartan Potassium | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Lawrenceville
- James TumlinLawrenceville$434K
- William PaxtonLawrenceville$73K
- Sharad VirmaniLawrenceville$55K
- Lorin SanchezLawrenceville$23K
- Aakash AminLawrenceville$22K
- Kathryn ElmoreLawrenceville$12K
- Shaun ConlonLawrenceville$11K
- Nnamdi NwaohiriLawrenceville$11K
- Jusong ChoiLawrenceville$8K
- Sagar PanseMacon$542K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.